Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 994

    1.

    Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.

    Ray D, Goswami R, Banerjee U, Dadhwal V, Goswami D, Mandal P, Sreenivas V, Kochupillai N.

    Diabetes Care. 2007 Feb;30(2):312-7.PMID: 17259500 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Prolonged (3-month) mycological cure rate after boric acid suppositories in diabetic women with vulvovaginal candidiasis.

    Ray D, Goswami R, Dadhwal V, Goswami D, Banerjee U, Kochupillai N.

    J Infect. 2007 Oct;55(4):374-7. Epub 2007 Aug 10.PMID: 17692922 [PubMed - indexed for MEDLINE]Related articles

    3.

    Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy.

    Goswami D, Goswami R, Banerjee U, Dadhwal V, Miglani S, Lattif AA, Kochupillai N.

    J Infect. 2006 Feb;52(2):111-7.PMID: 15908007 [PubMed - indexed for MEDLINE]Related articles

    4.

    [Treatment of recurrent vulvovaginal candidosis with mycosyst (fluconazole)]

    Pekhlivanov B, Amaliev I, Ivancheva Kh, Zisova L.

    Akush Ginekol (Sofiia). 2005;44 Suppl 2:25-7. Bulgarian. PMID: 16028400 [PubMed - indexed for MEDLINE]Related articles

    5.

    Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis.

    Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, Sperling M, Livengood C 3rd, Horowitz B, Von Thron J, Edwards L, Panzer H, Chu TC.

    N Engl J Med. 2004 Aug 26;351(9):876-83.PMID: 15329425 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Vulvovaginal candidiasis in a Flemish patient population.

    De Vos MM, Cuenca-Estrella M, Boekhout T, Theelen B, Matthijs N, Bauters T, Nailis H, Dhont MA, Rodriguez-Tudela JL, Nelis HJ.

    Clin Microbiol Infect. 2005 Dec;11(12):1005-11.PMID: 16307555 [PubMed - indexed for MEDLINE]Related articles

    7.

    [Comparative study of itraconazole and fluconazole therapy in vaginal candidosis]

    Vacheva-Dobrevski R, Kovachev S, Nacheva A, Stoev S, Vasilev N.

    Akush Ginekol (Sofiia). 2004;43(1):20-3. Bulgarian. PMID: 15168649 [PubMed - indexed for MEDLINE]Related articles

    9.

    Clinical and mycological efficacy of single-day oral treatment with itraconazole (400 mg) in acute vulvovaginal candidosis.

    Urünsak M, Ilkit M, Evrüke C, Urünsak I.

    Mycoses. 2004 Oct;47(9-10):422-7.PMID: 15504127 [PubMed - indexed for MEDLINE]Related articles

    10.

    Terconazole cream for non-Candida albicans fungal vaginitis: results of a retrospective analysis.

    Sood G, Nyirjesy P, Weitz MV, Chatwani A.

    Infect Dis Obstet Gynecol. 2000;8(5-6):240-3.PMID: 11220485 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Comparative study of fluconazole and clotrimazole for the treatment of vulvovaginal candidiasis.

    O-Prasertsawat P, Bourlert A.

    Sex Transm Dis. 1995 Jul-Aug;22(4):228-30.PMID: 7482105 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Vulvovaginal candidiasis: a therapeutic approach]

    Battaglia F, Mariani L, Anglana F, Milite V, Quattrini M, Plotti F, Tomao F, Plotti G.

    Minerva Ginecol. 2005 Apr;57(2):131-9. Review. Italian. PMID: 15940073 [PubMed - indexed for MEDLINE]Related articles

    13.

    Chronic vulvovaginal candidiasis: characteristics of women with Candida albicans, C glabrata and no candida.

    Geiger AM, Foxman B, Sobel JD.

    Genitourin Med. 1995 Oct;71(5):304-7.PMID: 7490047 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer.

    Bodey GP, Mardani M, Hanna HA, Boktour M, Abbas J, Girgawy E, Hachem RY, Kontoyiannis DP, Raad II.

    Am J Med. 2002 Apr 1;112(5):380-5.PMID: 11904112 [PubMed - indexed for MEDLINE]Related articles

    15.

    Fluconazole 150 mg single dose versus itraconazole 200 mg per day for 3 days in the treatment of acute vaginal candidiasis: a double-blind randomized study.

    De Punzio C, Garutti P, Mollica G, Nappi C, Piccoli R, Genazzani AR.

    Eur J Obstet Gynecol Reprod Biol. 2003 Feb 10;106(2):193-7.PMID: 12551791 [PubMed - indexed for MEDLINE]Related articles

    16.

    Comparative study on the effectiveness of antifungal agents in different regimens against vaginal candidiasis.

    Mikamo H, Kawazoe K, Sato Y, Hayasaki Y, Tamaya T.

    Chemotherapy. 1998 Sep-Oct;44(5):364-8.PMID: 9732153 [PubMed - indexed for MEDLINE]Related articles

    17.

    Recurrent vulvovaginal candidiasis.

    Ringdahl EN.

    Mo Med. 2006 Mar-Apr;103(2):165-8. Review.PMID: 16703718 [PubMed - indexed for MEDLINE]Related articles

    18.

    Treatment of vulvovaginal candidiasis with boric acid powder.

    Van Slyke KK, Michel VP, Rein MF.

    Am J Obstet Gynecol. 1981 Sep 15;141(2):145-8.PMID: 7282789 [PubMed - indexed for MEDLINE]Related articles

    19.

    Single dose oral fluconazole vs intravaginal terconazole in treatment of Candida vaginitis. Comparison and pilot study.

    Slavin MB, Benrubi GI, Parker R, Griffin CR, Magee MJ.

    J Fla Med Assoc. 1992 Oct;79(10):693-6.PMID: 1460451 [PubMed - indexed for MEDLINE]Related articles

    20.

    Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole.

    Sobel JD, Kapernick PS, Zervos M, Reed BD, Hooton T, Soper D, Nyirjesy P, Heine MW, Willems J, Panzer H, Wittes H.

    Am J Obstet Gynecol. 2001 Aug;185(2):363-9.PMID: 11518893 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data